What defines spirometry: pulmonary and extrapulmonary traits behind spirometric patterns
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) establishes airflow limitation (AL) dichotomised by FEV<sub>1</sub>/FVC <0.7 and its severity by FEV<sub>1</sub> %pred. This study aims to classify spirometric patterns globally by employing a similar dichochotomy: subjects with preserved ratio and reduced FEV<sub>1</sub> (PRISm); and AL assessed by reduced FEV<sub>1</sub> (rFlow, <80 %pred.GLI) or preserved FEV<sub>1</sub> (pFlow, ≥80 %pred.GLI). Associations between these patterns and baseline pulmonary and extrapulmonary characteristics were explored in the population-based Austrian LEAD study. Among 11547 subjects (18-82 years) with valid post-bronchodilator spirometry, 3.5% had PRISm, 4.1% pFlow and 3.0% rFlow. Lung volumes differed between groups with FEV<sub>1</sub>/FVC<0.7: rFlow were associated with higher RV/TLC while pFlow had the highest TLC and significantly reduced RV/TLC than rFlow. rFlow subjects also had the lowest MMEF (39.3±11.3 %pred.) and sGAW (0.8±0.4 1/kPa/s) compared to pFlow subjects (who shared similar sGAW with PRISm (1/kPa/s: 1.3±0.4 and 1.5±0.7)). Subjects with FEV<sub>1</sub>/FVC<0.7 were generally older (58.7±13.6 y) than their counterparts (PRISm, 45.9±18.3 y; normals, 44.9±16.9 y). An opposing effect of body composition (increased fat mass and visceral adipose tissue but decreased skeletal muscle mass) was found in FEV<sub>1</sub> <80%pred. threshold groups against their counterparts. Respiratory symptoms (dyspnoea, chronic cough, phlegm) varied significantly among spirometric pattern, with rFlow reporting the highest burden and pFlow markedly the lowest. Our data confirm clinical differences within participants with reduced FEV<sub>1</sub>/FVC ratio and that diseased states based on the GOLD-defined FEV<sub>1</sub> threshold should be contended.
Authors
- Robab Breyer‐Kohansal (ORCID: https://orcid.org/0000-0001-5850-5923)
- Marie‐Kathrin Breyer (ORCID: https://orcid.org/0000-0003-2086-8483)
- Tobias Mraz (ORCID: https://orcid.org/0009-0004-5523-2586)
- Emiel F.�M. Wouters (ORCID: https://orcid.org/0000-0002-9186-575X)
- Christoph Gross (ORCID: https://orcid.org/0000-0003-1583-5783)
- Sylvia Hartl (ORCID: https://orcid.org/0000-0002-0734-0070)
- Charmaine J. M. Helk-Lim
Institutions
- Sigmund Freud Privatuniversität Wien (AT)
- Maastricht University (NL)
- Klinik Hietzing (AT)
- Ludwig Boltzmann Institute for Lung Vascular Research (AT)
Publication Details
- Journal
- Epidemiology
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1183/13993003.congress-2024.pa3093
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00